Current Pharmacological Treatments in Type 1 Diabetes and Patient Tolerability against New Generation Medicines
<p id="p1">Type 1 diabetes mellitus (T1D) is an autoimmune condition characterized by insulin deficiency due to pancreatic beta-cell destruction. The global incidence of T1D has been increasing and reached 12 million patients in 2021. Diabetes is expected to rank third place, following cardiovascula...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2024
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/1199206 |
| Tags: |
No Tags, Be the first to tag this record!
|